BioXcel Therapeutics (BTAI) EPS (2017 - 2026)
BioXcel Therapeutics (BTAI) EPS from Dec 31, 2017 to Mar 31, 2026. The TTM BioXcel Therapeutics (BTAI) EPS is -$5.47. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
BioXcel Therapeutics (BTAI) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -64.65% |
| 3 Years | +22.44% |
| 5 Years | +12.91% |
| All Time | +7.64% |
Annual EPS change of BioXcel Therapeutics (BTAI)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.47 | -85.03% |
| 2025 | -$3.13 | -73.76% |
| 2024 | -$11.93 | +102.63% |
| 2022 | -$5.89 | +54.10% |
| 2021 | -$3.82 | +13.56% |
| 2020 | -$3.37 | +84.62% |
| 2019 | -$1.82 | +48.17% |
| 2018 | -$1.23 | +168.48% |
| 2017 | -$0.46 | N/A |